March 21, 2023 – New Brunswick – The Government of New Brunswick achieved an important milestone today by announcing an investment of $2.1 million to improve access to diabetes devices. The province will be expanding the insulin pump program by removing the existing age cap, updating the family contribution calculation, and including coverage for continuous […]
JDRF Canada and Diabetes Canada collaborate to close gaps in mental health support to improve quality of life for Canadians with diabetes
Mental health matters. Especially for those living with diabetes, a chronic condition affecting more than 4 million Canadians, that requires countless decisions every day about food, rest, play and more. Living with diabetes is a constant balancing act of planning nutrition, monitoring blood glucose, managing medications – and the fear from the risk of a myriad […]
Huge win for continuous glucose monitor (CGM) and insulin pump coverage for people with type 1 diabetes in Manitoba
Manitoba is the first province to completely remove the age restriction for these live-saving diabetes devices March 7, 2023 – Manitoba – On March 7, 2023, the government of Manitoba announced that it was investing $120 million in the Manitoba Pharmacare program in part to expand coverage of diabetes devices like insulin pumps and glucose […]
JDRF Canada is pleased to announce support of 7 trainees in the field of type 1 diabetes (T1D) in partnership with the Canadian Islet Research and Training Network
These training awards will support health researcher training to build capacity in the future of T1D research. CIRTN was established in 2020 as a world-class training and research network with joint contributions from the University of Alberta, University of British Columbia, University of Manitoba, Université de Montréal, Institut de Recherches Cliniques de Montréal, and the […]
JDRF Canada and Diabetes Canada are joining forces to accelerate diabetes research towards cures
JDRF Canada and Diabetes Canada are excited to announce how their combined funding efforts are helping to move diabetes research forward faster through support of two innovative projects focused on cutting-edge research on beta cells and islet replacement therapy. These two projects, which are supported through the JDRF-CIHR Partnership to Defeat Diabetes, are being funded […]
JDRF and its affiliates celebrate Teplizumab approval
This is a significant milestone for the type 1 diabetes community as teplizumab is the first drug that can delay the onset of type 1 diabetes in at-risk individuals Toronto, November 17, 2022 — JDRF, the leading global type 1 diabetes (T1D) research and advocacy organization, applauds today’s decision from the U.S Food and Drug […]
JDRF Canada is very excited to be part of the tabling of the National Diabetes Framework today by Minister Duclos
We want to thank everyone who led this incredible effort from Diabetes Canada in their unwavering pursuit of getting the Framework to where it is today, to MP Sidhu for taking this on as a private members bill. Thank you to Minister Duclos and the Government of Canada for recognizing the tremendous need for such […]
The Sun Life Ride to Defeat Diabetes for JDRF Brings Corporate Canada Together to Move Work Aside and Move for a Cure for Type 1 Diabetes
One of Canada’s longest running and top fundraising events returns to in-person Rides in Montréal and Toronto, on October 6 and 13 respectively. The Sun Life Ride to Defeat Diabetes for JDRF is a high-energy event that will see hundreds of corporate executives and teams don their spandex and team jerseys to pedal for a […]
JDRF Canada and Stem Cell Network announce the first recipient of the J. Andrew McKee Fellowship in Type 1 Diabetes News
Canada’s Stem Cell Network and JDRF Canada are pleased to announce Dr. Karoliina Tuomela as the inaugural J. Andrew McKee Fellow in Type 1 Diabetes (T1D). The announcement was made today in Vancouver at the Till & McCulloch Meetings, Canada’s premier stem cell and regenerative medicine conference. The J. Andrew McKee Fellowship in Type 1 […]
JDRF Announces Launch of global Type 1 Diabetes Index
The first-of-its-kind index will raise awareness of the burden and unmet need of people living with type 1 diabetes around the world. JDRF, the leading global type 1 diabetes (T1D) research and advocacy organization, announces the launch of the Type 1 Diabetes Index (T1D Index). The T1D Index is a first-of-its-kind data simulation tool that […]
All Canadians with type 1 diabetes will qualify for the Federal Disability Tax Credit
June 23, 2022, Toronto, ON – JDRF is thrilled to announce that the approximately 300,000 Canadians living with type 1 diabetes (T1D) can now automatically qualify for the federal disability tax credit. The disability tax credit (DTC) is a non-refundable tax credit that helps people with disabilities or their support people/family members reduce the amount […]
Government of Canada Approves $30M Joint Funding for Type 1 Diabetes Research
June 16, 2022 – JDRF Canada celebrates the approval of a joint investment of $30M for the JDRF-CIHR Partnership to Defeat Diabetes. We thank the government for this significant investment that will positively impact the type 1 diabetes (T1D) community. The JDRF-CIHR Partnership to Defeat Diabetes is a landmark collaboration between the Government of Canada, […]
